Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Sciformix Corporation and Cambridge Semantics Partner to Create Enhanced Pharmacovigilance Automation and Technology Platform for Life Science Companies
  • USA - English


News provided by

GRC

Apr 10, 2018, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Cambridge Semantics Logo
Cambridge Semantics Logo

BOSTON (PRWEB) April 10, 2018 -- Sciformix Corporation, a leading scientific knowledge-based organization, and Cambridge Semantics, The Smart Data Company®, today announced a partnership to launch a semantic technology layer, specifically tailored to pharmacovigilance processes that will transform and help interpret big data for the life science industry. This technology platform will allow Sciformix to further enhance its targeted pharmacovigilance automation suite for its clients.

Sciformix Corporation and Cambridge Semantics partner to impraove pharmacovigilance processes, and to transform and help interpret big data for the life science industry.

Post this

The solution combines Sciformix’s domain expertise in pharmacovigilance with Cambridge Semantics’ Anzo Smart Data Lake® to build safety-specific ontologies onto the platform, enabling life science companies to transform existing legacy data models into self-service analytics to maximize the value of their data. The semantic layer of technology on the data lake is able to process and make sense of vast quantities of structured and unstructured data to allow users to see patterns, signals and extract analytics from the information. The platform can help operationalize machine learning and artificial intelligence to allow it to improve over time and further automate practices, including case processing and medical review, enabling users to have fewer touch points with their data.

Sciformix President and CEO Manish Soman commented, “Sciformix is excited to announce this collaboration, which will enhance pharmacovigilance processes in the industry through a new, comprehensive end-to-end solution. We chose to work with the Cambridge Semantics open platform as it is scalable, capable of handling large quantities of data and able to provide advanced analytics. As the scientific work carried out by Sciformix and its clients is very data intensive, this was essential.”

He added, “The platform will enable us to provide a pharmacovigilance solution that will go beyond automating rule-based activities. It will leverage cognitive computing and artificial intelligence technologies based on machine learning and natural language processing (NLP) to build a comprehensive automation platform. This will improve the predictability of regulatory compliance and quality standards, and also allow teams to use the power of analytics to focus on complex, high-level downstream scientific work involving evaluation and interpretation activities.”

Alok Prasad, President of Cambridge Semantics said, “We are pleased to partner with Sciformix and extend their industry leading safety and pharmacovigilance expertise with our powerful Anzo Smart Data Lake product. Our semantically driven, big data graph platform will provide Sciformix with the unprecedented automation capabilities needed to process and understand vast amounts of medical information, enabling better patient safety for their clients.”

Both companies will be discussing this powerful solution set at World Drug Safety Congress, 2018 April 10-11th at the Hilton Philadelphia City Avenue at Booth 11. In addition Fran Bates, Vice President of Technology Services at Sciformix and Jim LaPointe, Managing Director at Cambridge Semantics, will be presenting together on “PV Automation Journey: Past, Present and Future” at 3:10 PM EST on April 10th.

Sciformix, headquartered in the United States with operations in Europe, India, and Philippines, partners with life science organizations to provide a full range of services, from study design to post-marketing surveillance. Areas of specialization include safety and risk management, clinical development, real world evidence and market research, scientific writing, regulatory affairs, and technology services.

To learn more about Sciformix, visit http://www.sciformix.com , email us at [email protected], or call us at +1.877.576.5005.

ENDS
For further press information please contact: Scott Girling-Heathcote, The Scott Partnership: + 44 1477 539539 mail to [email protected] or Susan Najjar, Director of Marketing, Sciformix Corporation: + 1 617-264-0339 mail to [email protected].
Media contact for Cambridge Semantics, Lora Wilson, Global Results Communications, [email protected], +1 (949) 608-0276

About Cambridge Semantics
Cambridge Semantics Inc., The Smart Data Company®, is a big data management and enterprise analytics software company that offers a universal semantic layer to connect and bring meaning to all enterprise data. Its software, the Anzo Smart Data Lake®, allows IT departments and their business users to semantically link, analyze and manage diverse data whether internal or external, structured or unstructured, with speed, at big data scales and at the fraction of the implementation costs of using traditional approaches. For more information visit http://www.cambridgesemantics.com.

About Sciformix
Sciformix Corporation is a leading scientific knowledge-based organization that provides process, technology and consulting services to the life sciences industry. We employ best-in-class strategies, technologies and expertise that accelerates business drives higher levels of performance and fosters innovation. What differentiates Sciformix is our ability to integrate scientific and technology expertise with quality driven processes to provide value to our clients throughout the entire drug development cycle. Our areas of specialization include Safety & Risk Management, Clinical Research & Post-Approval Support Services, Regulatory Affairs & Regulatory Operations, and Technology Services. Corporate headquarters is located in Westborough, MA with operations in NA, Europe, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science. For more information, please visit: https://www.sciformix.com

Lora Wilson, GRC, +1 9499297234, [email protected]

Modal title

Scifromix Logo
Scifromix Logo
Scifromix Logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.